Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation

FEBS Lett. 2000 May 26;474(1):111-5. doi: 10.1016/s0014-5793(00)01586-6.

Abstract

The S631C mutation in human ether-à-go-go-related gene (HERG) channels has previously been reported to disrupt C-type inactivation and ion-selectivity when Cys-631 is in the oxidized state. In this study, we report the relation between pharmacology and C-type inactivation for HERGS631C channels. We demonstrate that HERGS631C in its reduced state is fully blocked by 1 microM astemizole, terfenadine and dofetilide, similar to wild-type HERG channels. In contrast, oxidized HERGS631C is insensitive for these blockers. Our results suggest that an interaction with HERG channels in the inactivated state might be a common mechanism to a variety of drugs known to block HERG channels with high affinity.

MeSH terms

  • Animals
  • Astemizole / pharmacology
  • Cation Transport Proteins*
  • DNA-Binding Proteins*
  • ERG1 Potassium Channel
  • Electric Conductivity
  • Ether-A-Go-Go Potassium Channels
  • Female
  • Gene Expression
  • Humans
  • Microelectrodes
  • Mutation*
  • Oocytes / metabolism
  • Oxidation-Reduction
  • Patch-Clamp Techniques
  • Phenethylamines / pharmacology
  • Potassium Channels / drug effects*
  • Potassium Channels / genetics*
  • Potassium Channels / physiology
  • Potassium Channels, Voltage-Gated*
  • Sulfonamides / pharmacology
  • Terfenadine / pharmacology
  • Trans-Activators*
  • Transcriptional Regulator ERG
  • Transfection
  • Xenopus

Substances

  • Cation Transport Proteins
  • DNA-Binding Proteins
  • ERG protein, human
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • KCNH6 protein, human
  • Phenethylamines
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Sulfonamides
  • Trans-Activators
  • Transcriptional Regulator ERG
  • Terfenadine
  • Astemizole
  • dofetilide